Search results for " CD3"

showing 10 items of 92 documents

Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells.

2006

SummaryCD146 is an adhesion molecule present on endothelial cells throughout the vascular tree. CD146 is also expressed by circulating endothelial cells (CECs) widely considered to be mature endothelial cells detached from injured vessels. The discovery of circulating endothelial progenitor cells (EPCs) originating from bone marrow prompted us to investigate whether CD146 circulating cells could also contains EPCs. We tested this hypothesis using an approach combining elimination of CECs by an adhesion step, followed by immunomagnetic sorting of remaining CD146+ cells from the non adherent fraction of cord blood mononuclear cells. When cultured under endothelial-promoting conditions, these …

Pathologymedicine.medical_specialtyAngiogenesisCD 146CD34progenitor endothelial cellsMyocardial InfarctionNeovascularization PhysiologicAntigens CD34CD146 AntigenMice SCIDMicecirculating endothelial cellAntigens CDSettore BIO/10 - BiochimicamedicineAnimalsHumansCell LineageProgenitor cellCells CulturedCell Proliferationbusiness.industryStem CellsangiogenesiEndothelial CellsCell DifferentiationHematologyFetal BloodMolecular biologyEndothelial stem cellDrug CombinationsKineticsmedicine.anatomical_structurePhenotypeCord bloodModels Animalcardiovascular systemCD146Leukocyte Common AntigensProteoglycansBone marrowCollagenLamininStem cellbusinessThrombosis and haemostasis
researchProduct

Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs.

2004

Hematopoietic progenitor cell transplantation can contribute to revascularization of ischemic tissues. Yet, the optimal cell population to be transplanted has yet to be determined. We have compared the therapeutic potential of two subsets of human cord blood CD34+ progenitors, either expressing the VEGF-A receptor 2 (KDR) or not. In serum-free starvation culture, CD34+KDR+ cells reportedly showed greater resistance to apoptosis and ability to release VEGF-A, as compared with CD34+KDR- cells. When injected into the hind muscles in immunodeficient SCIDbg mice subjected to unilateral ischemia, a low number (10(3)) of CD34+KDR+ cells improved limb salvage and hemodynamic recovery better than a …

Pathologymedicine.medical_specialtyAngiogenesismedicine.medical_treatmentPopulationMuscle Fibers SkeletalIschemiaNeovascularization PhysiologicAntigens CD34ApoptosisRevascularizationBiochemistryMiceIschemiaGeneticsmedicineAnimalsHumansRegenerationeducationMuscle SkeletalMolecular Biologyeducation.field_of_studybusiness.industryRegeneration (biology)Stem CellsHemodynamicsKinase insert domain receptorExtremitiesmedicine.diseaseFetal BloodFibrosisVascular Endothelial Growth Factor Receptor-2TransplantationImmunologyStem cellbusinessBiotechnologyStem Cell TransplantationFASEB journal : official publication of the Federation of American Societies for Experimental Biology
researchProduct

Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro.

2002

EC culture models are essential to study pathological alterations of endothelial cells (ECs) in pulmonary vascular diseases under standardized conditions. Nevertheless, little is known about the spectrum of alterations of vessel-specific endothelial phenotypes in monolayer cultures. For the comparative study of endothelial markers in vivo and in vitro we investigated immunohistochemically the expression of PECAM-1, vWf, and CD34 by pulmonary ECs in vivo and in stimulated/unstimulated human umbilical vein endothelial cells (HU-VEC) and human pulmonary microvascular endothelial cells (HPMEC). In vivo, vessel type-specific expression patterns were found for vWf and CD34, while PECAM-1 was homo…

Pathologymedicine.medical_specialtyEndotheliumClinical BiochemistryCD34Antigens CD34BiologyIn Vitro TechniquesUmbilical veinPathology and Forensic MedicineIn vivovon Willebrand FactormedicineHumansMolecular BiologyLungCells CulturedMicrocirculationImmunohistochemistryIn vitroCell biologyEndothelial stem cellPlatelet Endothelial Cell Adhesion Molecule-1medicine.anatomical_structurePhenotypeCell culturecardiovascular systemEndothelium VascularBiomarkersBlood vesselExperimental and molecular pathology
researchProduct

CD15 – A new marker of pathological villous immaturity of the term placenta

2014

Abstract Introduction Idiopathic immaturity is one of the main reasons for latent placental insufficiency and antenatal hypoxia. Postnatal identification of the immature placental phenotype may help early stratification of a heterogeneous population of newborns and individually identify risk of disease in the immediate postnatal life. The aim of the study was to determine the relevant diagnostic markers associated with pathological placental immaturity. Methods 111 tissue samples from normal and pathological term placentas with persisting villous immaturity comprised the comparative immunohistochemical study (CD15, CD34). Positive immunohistochemical reactions were quantitatively assessed i…

Pathologymedicine.medical_specialtyEndotheliumLewis X AntigenAntigens CD34Placental insufficiencyBiologyPregnancyChronic VillitisFetal macrosomiamedicineHumansPathologicalPlacental villous immaturityAsphyxiaObstetrics and GynecologyHypoxia (medical)FucosyltransferasesPlacental Insufficiencymedicine.diseasemedicine.anatomical_structureReproductive MedicineCase-Control Studiesembryonic structuresImmunologyFemalemedicine.symptomBiomarkersDevelopmental BiologyPlacenta
researchProduct

Pulmonary haemangiolymphangioma – a new entity of pulmonary vascular tumours?

2008

Pathologymedicine.medical_specialtyPediatricsLung NeoplasmsHistologyMEDLINEAntigens CD34Lung pathologyPathology and Forensic MedicineHemangiomaAntibodies Monoclonal Murine-DerivedText miningAntigenBiomarkers TumormedicineHumansHemangioma CapillaryLungLymphangiomabiologybusiness.industryAntibodies MonoclonalGeneral Medicinemedicine.diseaseHemangioma CavernousFluorescent Antibody Technique DirectMonoclonalbiology.proteinAntibodybusinessHistopathology
researchProduct

Efficacy of photodynamic therapy in vulvar lichen sclerosus treatment based on immunohistochemical analysis of CD34, CD44, myelin basic protein, and …

2010

Introduction:Lichen sclerosus (LS) is a chronic skin and mucosa inflammatory disease. It affects mainly the female anogenital area especially in postmenopausal period. The main symptoms include pruritus, burning, pain, sometimes urinary problems, or difficulties in defecation. Usually, porcelain-white plaques are seen in the skin and mucosa. The etiology and pathogenesis of LS are still uncertain. There are some research studies on possible genetic predisposition, yet autoimmune, hormonal, or infectious factors are not excluded. The typical treatment of LS is mainly pharmacological, although the alternative treatment method used in LS is photodynamic therapy (PDT), which is noninvasive tech…

Pathologymedicine.medical_specialtyProliferation indexmedicine.medical_treatmentPhotodynamic therapyAntigens CD34Lichen sclerosusVulvar Lichen SclerosusPhotodynamic therapyVulvaPathogenesisGenetic predispositionmedicineHumansVulvar Lichen Sclerosusbiologybusiness.industryObstetrics and GynecologyMyelin Basic ProteinMiddle Agedmedicine.diseaseLichen sclerosusImmunohistochemistryMyelin basic proteinHyaluronan ReceptorsKi-67 AntigenTreatment OutcomeOncologyPhotochemotherapybiology.proteinImmunohistochemistryFemalebusinessInternational Journal of Gynecological Cancer
researchProduct

Identification of progenitor cancer stem cell in lentigo maligna melanoma.

2008

:  The potential role of stem cells in neoplasia has aroused considerable interest over the past few years. A number of known biologic characteristics of melanomas support the theory that they may originate in a mutated stem cell. Melanocytic stem cell markers have been described recently. Moreover, the CD133 cells that show surface markers for CD34 are stem cells primitive. These stem cells are capable of differentiating into neurons, glia, keratinocytes, smooth muscle cells, and melanocytes in vitro. The identification of cancer stem/initiating cells with a crucial role in tumor formation may open up new pharmacologic perspectives. The purpose of this study is to detect the expression of …

Pathologymedicine.medical_specialtySkin NeoplasmsCD34Antigens CD34DermatologyBiologyStem cell markerHutchinson's Melanotic FreckleCancer stem cellAntigens CDMelanoblastmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansAC133 AntigenLentigo maligna melanomaGlycoproteinsMelanomaGeneral Medicinemedicine.diseasecancer stem cell lentigo maligna melanomaNeoplastic Stem CellsMelanocytesStem cellPeptidesHair FollicleBiomarkersAdult stem cell
researchProduct

Proteomic Profiling of Secreted Proteins for the Hematopoietic Support of Interleukin-Stimulated Human Umbilical Vein Endothelial Cells

2013

Human umbilical cord vein endothelial cells (HUVECs) secrete a number of factors that greatly impact the proliferation and differentiation of hematopoietic stem and progenitor cells (HSPCs). These factors remain largely unknown. Here, we report on the most comprehensive proteomic profiling of the HUVEC secretome and identified 827 different secreted proteins. Two hundred and thirty-one proteins were found in all conditions, whereas 369 proteins were identified only under proinflammatory conditions following IL-1β, IL-3, and IL-6 stimulation. Thirteen proteins including complement factor b (CFb) were identified only under IL-1β and IL-3 conditions and may potentially represent HSPC prolifer…

ProteomicsSpectrometry Mass Electrospray IonizationInterleukin-1betaBiomedical EngineeringComplement C5blcsh:MedicineAntigens CD34BiologyComplement factor BUmbilical veinProinflammatory cytokineHuman Umbilical Vein Endothelial CellsHumansProgenitor cellCell ProliferationTransplantationInterleukin-6lcsh:RAntibodies MonoclonalComputational BiologyInterleukinComplement System ProteinsCell BiologyFlow CytometryHematopoietic Stem CellsMolecular biologyUp-RegulationComplement systemHaematopoiesisElectrophoresis Polyacrylamide GelInterleukin-3Stem cellPeptidesCell Transplantation
researchProduct

CD34+ progenitor to endothelial cell transition in post-pneumonectomy angiogenesis.

2012

In many species, pneumonectomy triggers compensatory lung growth that results in an increase not only in lung volume, but also in alveolar number. Whether the associated alveolar angiogenesis involves the contribution of blood-borne progenitor cells is unknown. To identify and characterize blood-borne progenitor cells contributing to lung growth after pneumonectomy in mice, we studied wild-type and wild-type/green fluorescence protein (GFP) parabiotic mice after left pneumonectomy. Within 21 days of pneumonectomy, a 3.2-fold increase occurred in the number of lung endothelial cells. This increase in total endothelial cells was temporally associated with a 7.3-fold increase in the number of …

Pulmonary and Respiratory MedicineTranscriptional ActivationPathologymedicine.medical_specialtyTime FactorsAngiogenesisCellular differentiationClinical BiochemistryGreen Fluorescent ProteinsCD34Neovascularization PhysiologicAntigens CD34Mice TransgenicBiologyMiceVasculogenesisCell MovementmedicineAnimalsRegenerationProgenitor cellPneumonectomyMolecular BiologyLungCell ProliferationStem CellsEndothelial CellsCell DifferentiationCell BiologyArticlesEndothelial stem cellVascular endothelial growth factor BMice Inbred C57BLGene Expression RegulationCancer researchStem cellAmerican journal of respiratory cell and molecular biology
researchProduct

Circulating CD34+ cells are decreased in chronic obstructive pulmonary disease.

2006

Pulmonary and Respiratory Medicineaged; antigens; biological markers; blood; blood/immunology; cd34; chronic obstructive; humans; pulmonary disease; severity of illness indexchronic obstructivebusiness.industryCd34 cellsPulmonary diseaseAntigens CD34cd34Severity of Illness IndexPulmonary Disease Chronic ObstructiveText miningantigensbloodImmunologyMedicineHumansblood/immunologybusinessbiological markersBiomarkerspulmonary diseaseAgedProceedings of the American Thoracic Society
researchProduct